Guizhou Utide Biotechnology logo

Guizhou Utide Biotechnology

Official Entity • China (Zunyi, Guizhou)

China-based GLP-1 peptide API manufacturer and CDMO, headquartered in Zunyi, Guizhou. Operates a 20,000m² cGMP facility with 200+ employees. Specializes in GLP-1 peptide APIs including semaglutide, tirzepatide, retatrutide, and cagrilintide. Holds U.S. DMFs for tirzepatide (DMF 042984) and retatrutide (DMF 043330). Core team has 20+ years of peptide R&D and GMP experience. Also operates as Guizhou MTpeptides Biotechnology Co., Ltd.

Official WebsiteReport Discrepancy
Verification Summary
ConfidenceMedium
Business TypeManufacturer
ModelManufacturer
RegionAsia
Verification status based on publicly available information and supplier-provided materials.
Products & Categories
Products
GLP-1 Peptide APIsCustom Peptide SynthesisCDMO ServicesSemaglutideTirzepatideRetatrutideCagrilintide
Capabilities
Peptide APIsCustom Synthesis
Categories
pharmaceuticalmanufacturer
Quality & Logistics
GMP CertifiedIn-House ProductionInternational ShippingCOAs Available
Verification Sources
Is this your company?

Claim this listing to update your information, respond to buyer inquiries, and get a verified badge.

  • Update your company details and products
  • Get a verified supplier badge
  • Receive buyer inquiries from our directory
Claim This Listing

Free to claim. Verified upgrades available.

Related Suppliers
BodyPharm UAE
UAE (Dubai) • Research Supplier
Sichuan Pengting Technology Co., Ltd.
China (Sichuan) • Bulk Wholesale
Shenzhen Bestbell Pharma
China (Shenzhen) • Manufacturer
Bachem Holding AG
Switzerland / USA • CDMO